Cresco Labs Inc. (CRLBF) Upgraded to Buy: Here's Why
Cresco Labs Inc. (CRLBF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
CRLBF - Cresco Labs Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$5.50
DETAILS
HIGH:
$8.50
LOW:
$2.50
MEDIAN:
$5.50
CONSENSUS:
$5.50
UPSIDE:
539.53%
Stock News
Cresco Labs Provides Update on Texas License Previously Awarded by Texas Department of Public Safety
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today provided an update on its application under the Texas Compassionate Use Program (TCUP). The Texas Department of Public Safety (DPS) has announced a retroactive correction to the tabulation methodology used in its conditional license selection process, impacting multiple applicants. Under the corrected tabulation, the conditional license previously awarded and publicly announced.
Cresco Labs Inc. (CRLBF) Q1 2026 Earnings Call Transcript
Cresco Labs Inc. (CRLBF) Q1 2026 Earnings Call Transcript
Cresco Labs Inc. (CRLBF) Reports Q1 Loss, Beats Revenue Estimates
Cresco Labs Inc. (CRLBF) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.04 per share a year ago.
Cresco Labs Reports First Quarter 2026 Financial Results, Advances Multiple Growth Initiatives
CHICAGO--(BUSINESS WIRE)--Cresco Labs Reports First Quarter 2026 Financial Results.
Why Fast-paced Mover Cresco Labs Inc. (CRLBF) Is a Great Choice for Value Investors
Cresco Labs Inc. (CRLBF) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Cresco Labs Opens Sunnyside Aberdeen, Marking Second Ohio Dispensary Opening in a Month
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today announced the grand opening of Sunnyside Aberdeen, located in Aberdeen, Ohio. This marks the Company's second Ohio dispensary opening in the past month, increasing its footprint to eight locations statewide and 74 nationally. “Sunnyside Aberdeen is our second dispensary opening in the state in a month, reflecting our commitment to serving more communities across Ohio,” said Cha.
Top Marijuana Stocks and Investment Outlook 2026
The cannabis industry in the United States is entering a new phase of sustained growth, positioning itself as one of the most closely watched emerging sectors for both investors and industry professionals. As legalization continues to expand at the state level, the legal framework supporting the cannabis industry is becoming stronger and more normalized. With only a handful of states yet to adopt full medical or adult-use programs, cannabis is approaching near-national acceptance, significantly increasing the total addressable market.
Marijuana Stocks: Industry Growth, Rescheduling Impact, and Outlook
The cannabis industry has become one of the most closely watched emerging sectors in global finance. As a result, marijuana stocks are attracting growing attention from both retail and institutional investors. Once viewed as speculative, the sector is now evolving into a more structured market. Currently, it is driven by stronger fundamentals, regulatory progress, and long-term consumer demand. As legalization expands and capital markets begin to open, the investment case for top marijuana stocks to buy is becoming more compelling. A major catalyst reshaping cannabis stocks has been the U.S. government's move toward rescheduling cannabis.
The Cannabis Sector's Billion-Dollar Tax Cut
On the heels of the executive order to fast-track research into psychedelic drugs, a second major federal policy shift on April 23, 2026, is sending waves through the cannabis sector. However, the real catalyst is being widely misunderstood by many on Wall Street.
Cresco Labs CEO: Rescheduling Ushers in a New Era of Care for Medical Cannabis Patients
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today issued a statement on behalf of Cresco Labs CEO Charlie Bachtell in response to the Department of Justice's final rule publication rescheduling medical cannabis from Schedule I to Schedule III under the Controlled Substances Act. “Rescheduling medical cannabis is a long-overdue step that finally brings federal policy closer to the science. For the first time in history, our fed.
Cresco Labs to Report First Quarter 2026 Financial Results on May 8, 2026
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the quarter ended March 31st, 2026 on Friday, May 8, 2026 before the market opens. The Company will host a conference call and webcast to discuss its financial results and provide investors with key bu.
3 Marijuana Stocks To Watch In 2026 For Better Trading
The cannabis industry is in a big battle between corporate growth and the small batch family farmers who came before legalization. For legal small batch and craft farmers, there is a fight to keep operations and legacy going. The way big MSOs are taking over with big money and corporate strategies has the market in a bit of a frenzy. For example, when a new customer, whether retail or medical, it can often be difficult to know who to shop with.
Top U.S. Marijuana Stocks to Watch as Cannabis Reform Gains Momentum
The U.S. cannabis sector continues to evolve as operators focus on profitability and efficiency. Meanwhile, speculation about federal reform remains a key catalyst. Investors are watching for progress on rescheduling and broader institutional access. As a result, multi-state operators are tightening operations and improving margins.
Cresco Labs Opens Sunnyside Bridgeport, Expanding Access in the Ohio Valley
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today announced the grand opening of Sunnyside Bridgeport, located at 435 Main Street in Bridgeport, Ohio. It's the Company's seventh dispensary in Ohio and 73rd nationwide. “We're proud to join the Bridgeport community and offer a positive, reliable shopper experience to the people of Belmont County,” said Charlie Bachtell, CEO of Cresco Labs. “Ohio is an important market for Cresco.
Best U.S. Cannabis Stocks for April 2026: Growth, Scale, and Opportunity
The U.S. cannabis sector continues to show strong long-term growth potential. The market is expected to expand significantly over the next several years. However, short-term volatility continues to affect stock performance across the sector. At the same time, investors are closely watching developments in federal reform. In addition, rescheduling discussions continue to support bullish sentiment. Meanwhile, state-level expansion remains strong across key markets.
Cresco Labs Awarded Texas Medical Cannabis License
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today announced that it has been conditionally awarded a Texas Compassionate Use Program License. It is a vertically integrated license, allowing Cresco Labs to cultivate, process and dispense medical cannabis. "Texas patients deserve access t.
Bloom Expands Partnership with Cresco Labs to Enter Pennsylvania's Vape-Forward Medical Market
PHILADELPHIA--(BUSINESS WIRE)--Bloom, a nationally recognized leader known for its proprietary hardware platform and refined strain formulations, is entering one of the country's largest medical-only cannabis markets with its launch in Pennsylvania in partnership with Cresco Labs (CSE: CL) (OTCQX: CRLBF), one of the largest multi-state cannabis operators in the U.S. This marks Bloom's second market launch with Cresco Labs, following a successful debut at Sunnyside dispensaries across Florida in.
3 Marijuana Stocks To Build A Stronger Portfolio
The cannabis industry is bringing much more attention to itself with every progressive step. Legal cannabis worldwide is becoming more accepted and treated like any other legitimate industry. This also brought in people looking to get involved in the sector. For most, this comes in the form of finding the best marijuana stocks to buy. However, if you are new to cannabis investing, there are steps that need to happen. First, you need to learn about pot stocks and which cannabis companies are publicly traded and dominating the industry.
Best U.S. Cannabis Stocks to Watch Right Now: March 2026 Edition
The U.S. cannabis sector continues evolving as legalization momentum builds. Additionally, companies are focusing on profitability and operational efficiency. Many investors are watching multi-state operators for growth opportunities. Furthermore, industry consolidation could create stronger long-term leaders.